Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-02 Sale | 2024-05-03 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 4,681 | $8.7378 | $40,902 | 145,505 (Direct) | View |
| 2024-03-04 Sale | 2024-03-06 5:08 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 3,468 | $11.12 | $38,568 | 146,020 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:54 pm | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks | 1,610 | $15.83 | $25,481 | 66,090 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-16 Option Award | 2024-05-17 4:20 pm | N/A 2034-05-16 | Ventyx Biosciences Inc. | VTYX | Moore Matthew Richard Chief Operating Officer | 320,000 | $0 | 320,000 (Direct) | View |
| 2024-05-01 Option Award | 2024-05-03 4:29 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 4,166 | $0 | 145,505 (Direct) | View |
| 2024-02-13 Disposition | 2024-02-15 6:47 pm | N/A 2031-01-19 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 247,300 | $0 | 149,488 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:47 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 68,232 | $0 | 149,488 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 4:28 pm | N/A 0034-01-12 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 154,000 | $0 | 180,590 (Direct) | View |
| 2023-08-29 Option Award | 2023-09-12 07:39 am | N/A 2031-01-18 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 12,500 | $0 | 12,500 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:54 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks | 54,400 | $0 | 66,090 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:46 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 48,600 | $0 | 48,600 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-21 8:07 pm | N/A 2031-01-19 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 160,000 | $0 | 160,000 (Direct) | View |